Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 USD | +0.23% | +1.69% | +59.51% |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.51% | 162.89Cr | |
+46.19% | 5.57TCr | |
-6.14% | 3.96TCr | |
+39.72% | 3.99TCr | |
-6.65% | 2.82TCr | |
+12.33% | 2.63TCr | |
-21.78% | 1.89TCr | |
-0.35% | 1.21TCr | |
+24.18% | 1.21TCr | |
+28.38% | 1.22TCr |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Transcript : Edgewise Therapeutics, Inc. Presents at Goldman Sachs 42nd Annual Global Healthcare Conference, Jun-09-2021 05